These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3193402

  • 1. Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine.
    Waelbroeck M, Robberecht P, De Neef P, Christophe J.
    J Recept Res; 1988; 8(6):787-808. PubMed ID: 3193402
    [Abstract] [Full Text] [Related]

  • 2. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M, Waelbroeck M, Christophe J.
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [Abstract] [Full Text] [Related]

  • 3. In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors.
    Gillard M, Waelbroeck M, Christophe J.
    J Recept Res; 1986 Jul; 6(1):47-61. PubMed ID: 3754901
    [Abstract] [Full Text] [Related]

  • 4. On the interaction of gallamine with muscarinic receptor subtypes.
    Michel AD, Delmendo RE, Lopez M, Whiting RL.
    Eur J Pharmacol; 1990 Jul 03; 182(2):335-45. PubMed ID: 2397745
    [Abstract] [Full Text] [Related]

  • 5. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1988 Sep 03; 246(3):829-38. PubMed ID: 3418516
    [Abstract] [Full Text] [Related]

  • 6. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes.
    Ellis J, Huyler J, Brann MR.
    Biochem Pharmacol; 1991 Oct 24; 42(10):1927-32. PubMed ID: 1741770
    [Abstract] [Full Text] [Related]

  • 7. Gallamine exerts biphasic allosteric effects at muscarinic receptors.
    Ellis J, Seidenberg M.
    Mol Pharmacol; 1989 Feb 24; 35(2):173-6. PubMed ID: 2918854
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effects of quinidine on rat heart muscarinic receptors.
    Waelbroeck M, De Neef P, Robberecht P, Christophe J.
    Life Sci; 1984 Sep 03; 35(10):1069-76. PubMed ID: 6482646
    [Abstract] [Full Text] [Related]

  • 9. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
    Sharif NA, Williams GW, DeSantis LM.
    Neurochem Res; 1995 Jun 03; 20(6):669-74. PubMed ID: 7566362
    [Abstract] [Full Text] [Related]

  • 10. Quaternary forms of classical muscarinic antagonists distinguish subpopulations of muscarinic receptors: correlation with gallamine-defined subpopulations.
    Ellis J, Lenox RH.
    Biochem Biophys Res Commun; 1985 Feb 15; 126(3):1242-50. PubMed ID: 3977914
    [Abstract] [Full Text] [Related]

  • 11. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
    Christopoulos A, Mitchelson F.
    Eur J Pharmacol; 1995 Aug 15; 290(3):259-62. PubMed ID: 7589221
    [Abstract] [Full Text] [Related]

  • 12. Effects of aging on the interaction of quinuclidinyl benzilate, N-methylscopolamine, pirenzepine, and gallamine with brain muscarinic receptors.
    Surichamorn W, Kim ON, Lee NH, Lai WS, el-Fakahany EE.
    Neurochem Res; 1988 Dec 15; 13(12):1183-91. PubMed ID: 3237310
    [Abstract] [Full Text] [Related]

  • 13. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
    Ehlert FJ.
    J Pharmacol Exp Ther; 1988 Nov 15; 247(2):596-602. PubMed ID: 3183955
    [Abstract] [Full Text] [Related]

  • 14. Mixed competitive and allosteric antagonism by gallamine of muscarinic receptor-mediated second messenger responses in N1E-115 neuroblastoma cells.
    Lee NH, el-Fakahany EE.
    J Neurochem; 1989 Oct 15; 53(4):1300-8. PubMed ID: 2549200
    [Abstract] [Full Text] [Related]

  • 15. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
    Schröter A, Tränkle C, Mohr K.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec 15; 362(6):512-9. PubMed ID: 11138843
    [Abstract] [Full Text] [Related]

  • 16. Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an "infinite dilution" procedure.
    Christopoulos A, Lanzafame A, Ziegler A, Mitchelson F.
    Biochem Pharmacol; 1997 Mar 21; 53(6):795-800. PubMed ID: 9113100
    [Abstract] [Full Text] [Related]

  • 17. Competition between positive and negative allosteric effectors on muscarinic receptors.
    Proska J, Tucek S.
    Mol Pharmacol; 1995 Oct 21; 48(4):696-702. PubMed ID: 7476896
    [Abstract] [Full Text] [Related]

  • 18. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S, Musílková J, Nedoma J, Proska J, Shelkovnikov S, Vorlícek J.
    Mol Pharmacol; 1990 Nov 21; 38(5):674-80. PubMed ID: 2233700
    [Abstract] [Full Text] [Related]

  • 19. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies.
    Cortés R, Palacios JM.
    Brain Res; 1986 Jan 08; 362(2):227-38. PubMed ID: 3942874
    [Abstract] [Full Text] [Related]

  • 20. Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors.
    Waelbroeck M.
    Mol Pharmacol; 1994 Oct 08; 46(4):685-92. PubMed ID: 7969047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.